ANGLE plc (LON:AGL)‘s stock had its “corporate” rating reissued by investment analysts at FinnCap in a note issued to investors on Tuesday. They presently have a GBX 108 ($1.42) price objective on the stock. FinnCap’s target price indicates a potential upside of 163.74% from the company’s current price.

Shares of ANGLE plc (AGL) opened at GBX 40.95 ($0.54) on Tuesday. ANGLE plc has a fifty-two week low of GBX 32.27 ($0.42) and a fifty-two week high of GBX 80 ($1.05).

TRADEMARK VIOLATION NOTICE: This report was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another site, it was copied illegally and republished in violation of United States and international copyright legislation. The legal version of this report can be viewed at

About ANGLE plc

ANGLE plc is a holding company. The Company’s principal activity is undertaken in relation to the commercialization of its Parsortix cell separation system, with deployment in non-invasive cancer diagnostics. The Company is a specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health.

Receive News & Stock Ratings for ANGLE plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE plc and related stocks with our FREE daily email newsletter.